Wendell Amy McBride 4

What Happened
Wendell Amy McBride, a director of Axogen, Inc. (AXGN), was granted 4,392 restricted stock units (RSUs) on June 24, 2026. The Form 4 reports these as a derivative award at $0 per share (i.e., a grant of contingent units). The grant was valued at approximately $185,000 and vests on June 24, 2027. This is an equity compensation award (routine director grant), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-24; Form 4 filed: 2026-06-26 (two days after the grant).
• Award: 4,392 RSUs granted, reported at $0.00 per unit on the Form 4 (derivative grant).
• Reported grant valuation: ~$185,000 (per company valuation used to determine award size).
• Vesting: 1-year cliff — vests on June 24, 2027.
• Shares owned after transaction: not specified in the provided filing details.
• Footnotes: F1 — each RSU represents a contingent right to receive one share of common stock; F2 — this is the annual equity grant for Board service based on a $185,000 valuation.
• Filing timeliness: Form filed two days after the transaction date (appears to meet the standard 2-business-day Form 4 deadline).

Context
RSU grants to directors are common as compensation for board service and should be viewed as routine corporate compensation rather than a direct trading signal. Because these are restricted units (derivative awards), no cash changed hands and the units will convert to shares only if and when they vest.